Le Lézard
Classified in: Health
Subject: PER

Proton Therapy Partners Welcomes New Member to Board of Directors


PHILADELPHIA, Dec. 6, 2019 /PRNewswire/ -- Proton Therapy Partners (PTP) is pleased to announce the addition of David L. Bernd to its Board of Directors. 

(PRNewsfoto/Proton Therapy Partners)

"It's an honor to welcome David to our Board of Directors," says Chris Dadlez, CEO of PTP. "David is a respected leader and innovator in the healthcare industry and will be a tremendous asset to PTP as we work to achieve our mission of improving outcomes, changing lives ?.  David possesses vast industry knowledge and experience that will help to strengthen and grow PTP nationally."

For more than 20 years, David L. Bernd served as the Chief Executive Officer of Sentara Healthcare, a $5.2 billion integrated health system headquartered in Norfolk, Va., comprised of 12 acute-care hospitals, with health plans covering 450,000 lives, 950+ provider medical groups and medical staffs of approximately 3,700 physicians. Under his leadership, Sentara developed a national reputation for safety, quality, and innovation, and Sentara facilities and programs have been recognized in the America's Best Hospitals rankings by U.S. News & World Report for the past 15 years. Mr. Bernd led the organization into a new era of health care, caring for defined populations and transforming the way health care is provided.  Mr. Bernd was recognized for his commitment to information technology with the 2010 CEO IT Achievement Award by Modern Healthcare.

Mr. Bernd was named by the U.S. Secretary of Commerce to serve as a member of the Measuring Innovation in the 21st Century Economy Advisory Committee of the Department of Commerce in 2006- 2007. He was Chair of the VHHA Board of Directors from November 1994-October 1995, and in 2004, Mr. Bernd served as chairman of the American Hospital Association Board of Trustees, making him the top elected official of the largest hospital and health system association in the United States.

Mr. Bernd serves on the Board of Visitors at Old Dominion University and served as Rector from 2010 ? 2012. In addition, he has served on the VHA, Inc. Board of Directors. In October 2014 Mr. Bernd was appointed by the Secretary of the Army as a Civilian Aide. He is past Chairman of the United Way of South Hampton Roads Board of Directors and the Metropolitan Board of YMCA of South Hampton Roads.

About Proton Therapy Partners (protontherapypartners.com)  
Proton Therapy Partners (PTP) is an innovative healthcare services company that offers a proven equity joint venture model to provide health systems with access to proton therapy at a lower cost and with a smaller footprint. Its internationally recognized executive and medical team understands the multiple complexities that come with building a proton therapy center and leverages its deep experience to provide a turn-key solution that includes overall project management, education and training. PTP's proven track record of success cuts across a variety of settings, including health systems, academic medical centers, comprehensive cancer centers, and community-based providers. PTP is a portfolio company of Concord Health Partners.

CONTACT: Nanci Gage, 770.845.4629, ngage@ptpnow.org

SOURCE Proton Therapy Partners


These press releases may also interest you

at 03:55
The Charité's ethics committee has approved the double-blind study on the tinnitus therapy device tinniwell with Resaphene Suisse AG, ISIN CH0367465439, WKN A2JG91. A total of 60 people took part in the study and the head is Prof. Dr. med. Birgit...

at 03:45
Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screeningtm, announced today that the Medical Retina Center and the Diabetic Retinopathy Telescreening...

at 03:01
Sirona Biochem Corp. (US-OTC: SRBCF)("Sirona" or the "Company") announces that it has granted an aggregate of 6,800,000 incentive stock options to management, independent directors and consultants of the Company. The options, to purchase common...

at 03:01
In 2020, businesses can expect a range of regulations to be enforced, including the delayed Strong Customer Authentication (SCA) requirement of the Second Payment Services Directive (PSD2). This requires financial service providers to provide two...

at 03:00
Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 213,886 of its own shares in the period from 13 January 2020 up to and including 17 January 2020 at an average price of ?109.84. This is in...

at 03:00
Genomenon® announced that over 175,000 recently documented genetic variants (DNA mutations) have been added to the Mastermind® Genomic Search Engine in the 4th quarter of 2019, for a cumulative total of more than 5.9 million genetic variants. This...



News published on 6 december 2019 at 13:14 and distributed by: